Wylie Burke

Last updated
Wylie Burke
Wylie Burke at HGP10 Symposium.jpg
Burke in 2013
Born
Utica, NY [1]
Alma mater University of Washington
Scientific career
Fields Genetics
Institutions University of Washington, Northwest-Alaska Pharmacogenomics Research Network
External media
Audio
Nuvola apps arts.svg “Wylie Burke on genomics, precision medicine, and healthcare policy”, podcast, Genome Alberta, July 10, 2015.
Video
Nuvola apps kaboodle.svg Risks and Benefits of Genetic Testing, Wylie Burke, University of Washington, November 22, 2013

Wylie Burke is a Professor Emerita and former Chair of the Department of Bioethics and Humanities at the University of Washington and a founding co-director of the Northwest-Alaska Pharmacogenomics Research Network, which partners with underserved populations in the Pacific Northwest and Alaska.

Contents

Burke's work focuses on ethical, legal, and social implications of genetic information for research and health care. She is an elected member of the National Academy of Medicine and the Association of American Physicians, and a past president of the American Society of Human Genetics.

Early life and education

Burke attended Brooklyn College, graduating summa cum laude in 1970. She then studied at the University of Washington, receiving a PhD in Genetics in 1974 and completing her MD with a residency in Internal Medicine. [1] [2] Next she spent several years as a primary care doctor at a community hospital. [3] Burke returned to the University of Washington as a Medical Genetics Fellow from 1981-1982. [4]

Career

Burke joined the Department of Medicine at the University of Washington in 1983. She served as the associate director of the Internal Medicine Residency Program from 1988 to 1994 and as the founding director of the Women’s Health Care Center at the University of Washington from 1994-1999. In 2000, she became director of the Department of Medical History and Ethics. It was renamed the Department of Bioethics and Humanities in 2008. Burke stepped down as chair in 2014. [1] [4]

Burke is now Professor Emerita of the University of Washington. She is also an adjunct professor of medicine and epidemiology and a member of the Fred Hutchinson Cancer Research Center. The Department of Bioethics & Humanities at the University of Washington has created an endowed scholarship for diversity in her name. [5]

Burke was a visiting scientist at the Centers for Disease Control and Prevention in 1998. She served on the NIH National Advisory Council for Human Genome Research from 1999-2003 and the Department of Health and Human Services Advisory Committee on Genetic Testing from 1999-2002. [6] Burke was the founding Principal Investigator of the University of Washington's Center for Genomics and Healthcare Equality from 2004–2017, one of the NIH Centers of Excellence in Ethical, Legal and Social Implications (ELSI) Research, which were funded by the National Human Genome Research Institute. [3] [7] [8] [9] She served on the National Academies' Committee on the Return of Individual-Specific Results Generated in Research Laboratories, which released a report in 2018 recommending guidelines for researchers and institutions. [10] [11]

Burke is a founding co-director with Ken Thummel of the Northwest-Alaska Pharmacogenomics Research Network. [12] The network was formed in 2009 as a research partnership between tribal organizations and universities [3] to study pharmacogenomics in rural and underserved populations in the Pacific Northwest and Alaska. [12] [13] [14] [15] It received funding from the National Institutes of Health (NIH). [16] American Indian and Alaska Native (AI/AN) people are disproportionately likely to be designated as medically underserved, as a result of lower availability of primary care physicians and higher than average percentages for infant mortality, incomes below the poverty level, and people 65 years or older. [17] Current university partners include the University of Washington, the University of Alaska Fairbanks, the Oregon Health & Science University, and the University of Montana. [18]

Burke has been an international fellow at the National Health Service in Cambridge, United Kingdom. [19] Burke was director of the American Society of Human Genetics (ASHG) from 2002 to 2004 and a member of its Social Issues Committee from 2004 to 2006. In 2007 she served as ASHG President. [1] [20]

Research

Burke examines the ethical, legal, and social implications of human genetics. She is particularly concerned with the translation of novel genomic technologies from their development in the lab to their use in the health system and community. [21] She is regarded as a national leader in ethics and policy dealing with human genome research, addressing fundamental and difficult questions with respect for those involved. [7]

Among the issues of concern to Burke are clinical utility — what genetic information will be of help to a particular patient, how can this be determined, and are there potential harms to a patient? — and equity — are interventions which have clinical utility available to all who can benefit from it? Are diverse populations and individuals being taken into account? [3]

Awards

Publications

Related Research Articles

The Human Genome Organisation (HUGO) is a non-profit organization founded in 1988. HUGO represents an international coordinating scientific body in response to initiatives such as the Human Genome Project. HUGO has four active committees, including the HUGO Gene Nomenclature Committee (HGNC), and the HUGO Committee on Ethics, Law and Society (CELS).

<span class="mw-page-title-main">Pharmacogenomics</span> Study of the role of the genome in drug response

Pharmacogenomics is the study of the role of the genome in drug response. Its name reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response, by correlating DNA mutations with pharmacokinetic, pharmacodynamic, and/or immunogenic endpoints.

<span class="mw-page-title-main">National Human Genome Research Institute</span> Institute of the National Institutes of Health, located in Bethesda, Maryland, US

The National Human Genome Research Institute (NHGRI) is an institute of the National Institutes of Health, located in Bethesda, Maryland.

<span class="mw-page-title-main">Personalized medicine</span> Medical model that tailors medical practices to the individual patient

Personalized medicine, also referred to as precision medicine, is a medical model that separates people into different groups—with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine, precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept though some authors and organisations use these expressions separately to indicate particular nuances.

<span class="mw-page-title-main">Thiopurine methyltransferase</span>

Thiopurine methyltransferase or thiopurine S-methyltransferase (TPMT) is an enzyme that in humans is encoded by the TPMT gene. A pseudogene for this locus is located on chromosome 18q.

<span class="mw-page-title-main">Mary-Claire King</span> American geneticist

Mary-Claire King is an American geneticist. She was the first to show that breast cancer can be inherited due to mutations in the gene she called BRCA1. She studies human genetics and is particularly interested in genetic heterogeneity and complex traits. She studies the interaction of genetics and environmental influences and their effects on human conditions such as breast and ovarian cancer, inherited deafness, schizophrenia, HIV, systemic lupus erythematosus and rheumatoid arthritis. She has been the American Cancer Society Professor of the Department of Genome Sciences and of Medical Genetics in the Department of Medicine at the University of Washington since 1995.

Public health genomics is the use of genomics information to benefit public health. This is visualized as more effective preventive care and disease treatments with better specificity, tailored to the genetic makeup of each patient. According to the Centers for Disease Control and Prevention (U.S.), Public Health genomics is an emerging field of study that assesses the impact of genes and their interaction with behavior, diet and the environment on the population's health.

Personal genomics or consumer genetics is the branch of genomics concerned with the sequencing, analysis and interpretation of the genome of an individual. The genotyping stage employs different techniques, including single-nucleotide polymorphism (SNP) analysis chips, or partial or full genome sequencing. Once the genotypes are known, the individual's variations can be compared with the published literature to determine likelihood of trait expression, ancestry inference and disease risk.

<span class="mw-page-title-main">Aravinda Chakravarti</span> American geneticist

Aravinda Chakravarti is a human geneticist and expert in computational biology, and Director of the Center For Human Genetics & Genomics at New York University. He was the 2008 President of the American Society of Human Genetics. Chakravarti became a co-Editor-in-Chief of the journal Genome Research in 1995, and of the Annual Review of Genomics and Human Genetics' in 2005.

Return of results is a concept in research ethics which describes the extent of the duty of a researcher to reveal and explain the results of research to a research participant.

Dr. Vinod Scaria FRSB, FRSPH is an Indian biologist, medical researcher pioneering in Precision Medicine and Clinical Genomics in India. He is best known for sequencing the first Indian genome. He was also instrumental in the sequencing of The first Sri Lankan Genome, analysis of the first Malaysian Genome sequencing and analysis of the Wild-type strain of Zebrafish and the IndiGen programme on Genomics for Public Health in India

Personalized medicine involves medical treatments based on the characteristics of individual patients, including their medical history, family history, and genetics. Although personal genetic information is becoming increasingly important in healthcare, there is a lack of sufficient education in medical genetics among physicians and the general public. For example, pharmacogenomics is practiced worldwide by only a limited number of pharmacists, although most pharmacy colleges in the United States now include it in their curriculum. It is also increasingly common for genetic testing to be offered directly to consumers, who subsequently seek out educational materials and bring their results to their doctors. Issues involving genetic testing also invariably lead to ethical and legal concerns, such as the potential for inadvertent effects on family members, increased insurance rates, or increased psychological stress.

Elective genetic and genomic testing are DNA tests performed for an individual who does not have an indication for testing. An elective genetic test analyzes selected sites in the human genome while an elective genomic test analyzes the entire human genome. Some elective genetic and genomic tests require a physician to order the test to ensure that individuals understand the risks and benefits of testing as well as the results. Other DNA-based tests, such as a genealogical DNA test do not require a physician's order. Elective testing is generally not paid for by health insurance companies. With the advent of personalized medicine, also called precision medicine, an increasing number of individuals are undertaking elective genetic and genomic testing.

<span class="mw-page-title-main">Charles Rotimi</span> Nigerian geneticist

Charles Nohuoma Rotimi is the Scientific Director of the National Human Genome Research Institute (NHGRI). He joined the National Institutes of Health (NIH) in 2008 as the inaugural Director of the Trans-NIH Center for Research in Genomics and Global Health and was also the chief of the NHGRI's Metabolic, Cardiovascular, and Inflammatory Disease Genomics Branch. He works to ensure that population genetics include genomes from African populations and founded the African Society of Human Genetics in 2003 and was elected its first president. Rotimi was instrumental in the launch of the Human Heredity and Health in Africa (H3Africa) with the NIH and the Wellcome Trust. He was elected to the National Academy of Medicine in 2018.

Náníbaaʼ Garrison (Diné) is a bioethicist, geneticist, and associate professor in the Institute for Society and Genetics and Department of Internal Medicine at the University of California, Los Angeles. She is a member of the Navajo Nation, and her career has focused on studies of health conditions prevalent in, and attitudes toward genetics research among, the Navajo community.

Charmaine DM Royal is an American geneticist and Associate Professor at the Institute for Genome Sciences & Policy and the Department of African and African American Studies at Duke University. She studies the intersections of race, ethnicity, ancestry genetics, and health, especially as they pertain to historically marginalized and underrepresented groups in genetic and genomic research; and genomics and global health. Her major interest is in addressing root causes and implementing sustainable solutions regarding problems of race and racism in research, healthcare, and society. Royal is a Human Heredity and Health in Africa (H3Africa) Independent Expert Committee (IEC) member appointed by the National Institutes of Health (NIH) and is a 2020 Ida Cordelia Beam Distinguished Visiting Professor at the University of Iowa.

Janina M. Jeff is a US-based geneticist and a senior scientist at Illumina. She is specifically interested in identifying genetic variants that explain disease disparities across populations, as well as science communication. She was the first African American to earn a PhD in Human Genetics at Vanderbilt University.

Howard L. McLeod is an American pharmacogeneticist and implementation scientist specialized in precision medicine.

<span class="mw-page-title-main">Vardit Ravitsky</span> Bioethicist, researcher, and author

Vardit Ravitsky is a bioethicist, researcher, and author. She is president and CEO of The Hastings Center, a full professor at the University of Montreal, and a senior lecturer on Global Health and Social Medicine at Harvard Medical School. She is immediate-past president and current vice-president of the International Association of Bioethics, and the director of Ethics and Health at the Center for Research on Ethics. She is a Fellow of the Pierre Elliott Trudeau Foundation, where she chaired the COVID-19 Impact Committee. She is also Fellow of The Hastings Center and of the Canadian Academy of Health Sciences.

<span class="mw-page-title-main">Deborah Nickerson</span> American human genomics researcher (1954–2021)

Deborah Ann "Debbie" Nickerson was an American human genomics researcher. She was professor of genome sciences at the University of Washington. Nickerson founded and directed of one of the five clinical sites of the Gregor Consortium and was a major contributor to many genomics projects, including the Human Genome Project and the International HapMap Project.

References

  1. 1 2 3 4 Ratzel, Sarah; Cullinan, Sara B. (November 3, 2016). "Wylie Burke, M.D., Ph.D., President, American Society of Human Genetics, 2007". The American Journal of Human Genetics. 99 (5): 1001–1224. doi: 10.1016/j.ajhg.2016.10.007 .
  2. ↑ "2020 Advancing Ethical Research Virtual Conference". 2020 Advancing Ethical Research Conference. Retrieved 7 February 2022.
  3. 1 2 3 4 Burke, Wylie (31 August 2021). "Utility and Diversity: Challenges for Genomic Medicine". Annual Review of Genomics and Human Genetics. 22 (1): 1–24. doi: 10.1146/annurev-genom-120220-082640 . ISSN   1527-8204. PMID   33792358. S2CID   232483454.
  4. 1 2 Institute of Medicine (20 June 2013). The Economics of Genomic Medicine: Workshop Summary. Washington, D.C.: National Academies Press. ISBN   978-0-309-26973-5 . Retrieved 7 February 2022.
  5. ↑ "2022 Wylie Burke Endowed Scholarship for Diversity!". UW Department of Bioethics & Humanities. Retrieved 7 February 2022.
  6. 1 2 "2016 Cowan Memorial Lectureships with Wylie Burke, MD, PhD". School of Medicine, University of Utah. March 11, 2016. Retrieved 7 February 2022.
  7. 1 2 3 Foster, Krystal (12 July 2021). "ASHG Honors Wylie Burke, MD, PhD with the 2021 Victor A. McKusick Leadership Award". American Society of Human Genetics. Retrieved 7 February 2022.
  8. ↑ "Wylie Burke, MD, PhD". UW Department of Bioethics & Humanities. Retrieved 7 February 2022.
  9. ↑ Herndon, Megan (November 16, 2015). "UW Ph.D. candidates working to include indigenous voices in genomic research". The Daily of the University of Washington. Retrieved 7 February 2022.
  10. ↑ "New Report Says Individual Research Results Should Be Shared With Participants More Often; Recommends Framework for Decision-Making". National Academies of Sciences, Engineering, and Medicine. July 10, 2018. Retrieved 8 February 2022.
  11. ↑ Division, Health Medicine (2018). Returning Individual Research Results to Participants: Guidance for a New Research Paradigm. National Academies Press. ISBN   9780309475174 . Retrieved 8 February 2022.{{cite book}}: |website= ignored (help)
  12. 1 2 "CANHR researchers team up to study drug/gene interaction" (PDF). News from the Center for Alaska Native Health Research. 8 (1). 2011. Retrieved 7 February 2022.
  13. ↑ "Pharmacogenomics Research Network (PGRN)". School of Pharmacy. University of Washington. Retrieved 7 February 2022.
  14. ↑ "Parent Project Number 5P01GM116691-05". NIH Reporter. Retrieved 7 February 2022.
  15. ↑ Morales, Chelsea T.; Muzquiz, LeeAnna I.; Howlett, Kevin; Azure, Bernie; Bodnar, Brenda; Finley, Vernon; Incashola, Tony; Mathias, Cheryl; Laukes, Cindi; Beatty, Patrick; Burke, Wylie; Pershouse, Mark A.; Putnam, Elizabeth A.; Trinidad, Susan Brown; James, Rosalina; Woodahl, Erica L. (2016). "Partnership with the Confederated Salish and Kootenai Tribes: Establishing an Advisory Committee for Pharmacogenetic Research". Progress in Community Health Partnerships: Research, Education, and Action. 10 (2): 169–170. doi:10.1353/cpr.2016.0029. ISSN   1557-0541. PMC   5850964 . PMID   27346761.
  16. ↑ "Improving Care for Alaska Native People". University of Washington, School of Pharmacy. 13 September 2019. Retrieved 8 February 2022.
  17. ↑ Woodahl, Erica L; Lesko, Lawrence J; Hopkins, Scarlett; Robinson, Renee F; Thummel, Kenneth E; Burke, Wylie (2014). "Pharmacogenetic research in partnership with American Indian and Alaska Native communities". Pharmacogenomics. 15 (9): 1235–1241. doi:10.2217/pgs.14.91. ISSN   1462-2416. PMC   4201360 . PMID   25141898.
  18. ↑ "Northwest-Alaska Pharmacogenetic Research Network". UW Research. Retrieved 8 February 2022.
  19. ↑ National Research Council (2014). "Appendix C: Biographical Sketches of Steering Committee Members and Presenters". Issues in returning individual results from genome research using population-based banked specimens, with a focus on the National Health and Nutrition Examination Survey : workshop summary. Washington, D.C.: The National Academies Press. ISBN   978-0-309-30704-8 . Retrieved 7 February 2022.
  20. ↑ Burke, Wylie (May 2008). "ASHG Presidential Address: Who Is under the Umbrella—and Why Are We Here?" (PDF). The American Journal of Human Genetics. 82 (5): 1029–1031. doi:10.1016/j.ajhg.2008.04.010. PMC   2427266 . PMID   20529637 . Retrieved 7 February 2022.
  21. 1 2 "Wylie Burke Named UCSF Presidential Chair". UCSF School of Nursing. Retrieved 7 February 2022.
  22. ↑ "National Academy of Medicine (formerly Institute of Medicine)". UW Research. Retrieved 7 February 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.